Perspective Therapeutics (CATX) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Perspective Therapeutics (CATX) over the last 3 years, with Q3 2025 value amounting to -$0.35.
- Perspective Therapeutics' EPS (Weighted Average and Diluted) fell 6666.67% to -$0.35 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.51, marking a year-over-year increase of 258.06%. This contributed to the annual value of -$0.01 for FY2024, which is 9915.34% up from last year.
- According to the latest figures from Q3 2025, Perspective Therapeutics' EPS (Weighted Average and Diluted) is -$0.35, which was down 6666.67% from -$0.3 recorded in Q2 2025.
- In the past 5 years, Perspective Therapeutics' EPS (Weighted Average and Diluted) ranged from a high of $0.01 in Q1 2023 and a low of -$0.91 during Q4 2023
- Its 3-year average for EPS (Weighted Average and Diluted) is -$0.35, with a median of -$0.3 in 2025.
- Data for Perspective Therapeutics' EPS (Weighted Average and Diluted) shows a peak YoY increase of 5500.0% (in 2024) and a maximum YoY decrease of 260000.0% (in 2024) over the last 5 years.
- Over the past 3 years, Perspective Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.91 in 2023, then soared by 32.97% to -$0.61 in 2024, then skyrocketed by 42.62% to -$0.35 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.35 for Q3 2025, versus -$0.3 for Q2 2025 and -$0.25 for Q1 2025.